Vivos Therapeutics (VVOS) Other Working Capital Changes (2020 - 2026)

Vivos Therapeutics (VVOS) has 7 years of Other Working Capital Changes data on file, last reported at $18000.0 in Q1 2026.

• On a quarterly basis, Other Working Capital Changes rose 154.55% year-over-year to $18000.0 in Q1 2026; TTM through Mar 2026 was $106000.0, a 180.3% increase from a year earlier, with the FY2025 full-year figure at $55000.0, up 142.64% from the prior year.
• Other Working Capital Changes for Q1 2026 stood at $18000.0, down from $510000.0 in the prior quarter.
• Over the last five years, Other Working Capital Changes for VVOS reached as high as $680000.0 in Q1 2022 and fell as low as -$667000.0 in Q4 2022.
• Historically, Other Working Capital Changes has averaged -$37882.4 across 5 years, with a median of -$102000.0 in 2023.
• Across the five-year window, Other Working Capital Changes surged 9950.0% in 2022 and sank 825.93% in 2024, its largest moves.
• Year by year, Other Working Capital Changes stood at $456000.0 in 2022, then tumbled by 30.92% to $315000.0 in 2023, then jumped by 155.87% to $806000.0 in 2024, then sank by 36.72% to $510000.0 in 2025, then plunged by 96.47% to $18000.0 in 2026.
• Per Business Quant data, the three most recent Other Working Capital Changes figures were $18000.0 in Q1 2026, $510000.0 in Q4 2025, and $53000.0 in Q3 2025.